Human urotensin II promotes hypertension and atherosclerotic cardiovascular diseases.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Current Medicinal Chemistry

• Publication date

  2009-01-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/092986709787458515PMID 19199921
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nonpeptide Urotensin-II receptor agonists and antagonists: review and structure-activity relationships.

  2008cited by this paper
• The role of urotensin II in the metabolic syndrome.

  2008cited by this paper
• Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular disease

  2008cited by this paper
• Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.

  2008cited by this paper
• Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice

  2008cited by this paper
• Comparative understanding of UTS2 and UTS2R genes for their involvement in type 2 diabetes mellitus

  2008cited by this paper
• Urotensin II and Cardiomyopathy in End-Stage Renal Disease

  2008cited by this paper
• Involvement of reactive oxygen species in urotensin II-induced proliferation of cardiac fibroblasts.

  2008cited by this paper
• Angiotensin II Upregulates Acyl-CoA:Cholesterol Acyltransferase-1 via the Angiotensin II Type 1 Receptor in Human Monocyte-Macrophages

  2008cited by this paper
• EFFECT OF UROTENSIN II ON SKIN MICROVESSEL TONE IN DIABETIC PATIENTS WITHOUT HEART FAILURE OR ESSENTIAL HYPERTENSION

  2008cited by this paper
• Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy.

  2008cited by this paper
• Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: relevance to function.

  2008cited by this paper
• Urotensin II induces phenotypic differentiation, migration, and collagen synthesis of adventitial fibroblasts from rat aorta

  2008cited by this paper
• Urotensin-II in the lung: A matter for vascular remodelling and pulmonary hypertension?

  2007cited by this paper
• Does cigarette smoking increase plasma urotensin II concentrations?

  2007cited by this paper
• Role of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstriction.

  2007cited by this paper
• Urotensin II is a New Chemotactic Factor for UT Receptor-Expressing Monocytes1

  2007cited by this paper
• Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans.

  2007cited by this paper
• Human Urotensin II as a Link between Hypertension and Coronary Artery Disease

  2006cited by this paper
• The Effects of Urotensin‐II on Proliferation of Pheochromocytoma Cells and mRNA Expression of Urotensin‐II and Its Receptor in Pheochromocytoma Tissues

  2006cited by this paper
• Proliferation and anti-apoptotic effects of human urotensin II on human endothelial cells.

  2006cited by this paper
• Association of ACE, ACE2 and UTS2 Polymorphisms with Essential Hypertension in Han and Dongxiang Populations from North-western China

  2006cited by this paper
• Urotensin-II levels in acute coronary syndromes.

  2006cited by this paper
• Human Urotensin-II Potentiates the Mitogenic Effect of Mildly Oxidized Low-Density Lipoprotein on Vascular Smooth Muscle Cells: Comparison with Other Vasoactive Agents and Hydrogen Peroxide

  2006cited by this paper
• Exercise urotensin II dynamics in myocardial infarction survivors with and without hypertension.

  2006cited by this paper
• Serotonin acts as an up-regulator of acyl-coenzyme A:cholesterol acyltransferase-1 in human monocyte-macrophages.

  2006cited by this paper
• Effects of hydrogen sulfide on hypoxic pulmonary vascular structural remodeling.

  2006cited by this paper
• Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance.

  2006cited by this paper
• Alteration of vascular urotensin II receptor in mice with apolipoprotein E gene knockout.

  2006cited by this paper
• Enhancement of vascular smooth muscle cell migration by urotensin II

  2006cited by this paper
• Urotensin-II and cardiovascular diseases

  2006cited by this paper
• Renal and vascular actions of urotensin II.

  2006cited by this paper
• Urotensin II and biomarkers of endothelial activation and atherosclerosis in end-stage renal disease.

  2006cited by this paper
• Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease.

  2006cited by this paper
• Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation.

  2006cited by this paper
• The Urotensin-II Receptor Antagonist Palosuran Improves Pancreatic and Renal Function in Diabetic Rats

  2006cited by this paper
• Pharmacodynamics and pharmacokinetics of the urotensin II receptor antagonist palosuran in macroalbuminuric, diabetic patients

  2006cited by this paper
• Circulating urotensin II levels in moderate to severe congestive heart failure: its relations with myocardial function and well established neurohormonal markers.

  2006cited by this paper
• Urotensin-II is a nitric oxide-dependent vasodilator in the pial arteries of the newborn pig.

  2006cited by this paper
• Expression of urotensin-II in human coronary atherosclerosis.

  2005cited by this paper
• Human Urotensin II Accelerates Foam Cell Formation in Human Monocyte-Derived Macrophages

  2005cited by this paper
• Role of prostaglandins in urotensin II-induced vasodilatation in the coronary arteries of aged rats.

  2005cited by this paper
• Urotensin II: Ancient Hormone with New Functions in Vertebrate Body Fluid Regulation

  2005cited by this paper
• Urotensin II: evidence for cardiac, hepatic and renal production.

  2005cited by this paper
• Human Urotensin II Is a Novel Activator of NADPH Oxidase in Human Pulmonary Artery Smooth Muscle Cells

  2005cited by this paper
• Structure–activity relationship study on human urotensin II

  2005cited by this paper
• A role for urotensin II in restenosis following balloon angioplasty: use of a selective UT receptor blocker.

  2005cited by this paper
• Effect of exogenous urotensin-II on vascular tone in skin microcirculation of patients with essential hypertension.

  2005cited by this paper
• Behavioral effects of urotensin-II centrally administered in mice

  2005cited by this paper
• Arrestin-Independent Internalization and Recycling of the Urotensin Receptor Contribute to Long-Lasting Urotensin II–Mediated Vasoconstriction

  2005cited by this paper
• Increased plasma levels of Urotensin-II in preeclampsia-eclampsia: a new mediator in pathogenesis?

  2005cited by this paper
• Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors.

  2004cited by this paper
• Pharmacology of the Urotensin-II Receptor Antagonist Palosuran (ACT-058362; 1-[2-(4-Benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea Sulfate Salt): First Demonstration of a Pathophysiological Role of the Urotensin System

  2004cited by this paper
• Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries.

  2004cited by this paper
• Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy.

  2004cited by this paper
• Urotensin-II: a novel systemic hypertensive factor in the cat

  2004cited by this paper
• Genetic variations at urotensin II and urotensin II receptor genes and risk of type 2 diabetes mellitus in Japanese.

  2004cited by this paper
• Identification and pharmacological characterization of native, functional human urotensin‐II receptors in rhabdomyosarcoma cell lines

  2004cited by this paper
• Urotensin-II-Converting Enzyme Activity of Furin and Trypsin in Human Cells in Vitro

  2004cited by this paper
• Adiponectin down-regulates acyl-coenzyme A:cholesterol acyltransferase-1 in cultured human monocyte-derived macrophages.

  2004cited by this paper
• Plasma concentration of urotensin II is raised in hypertension

  2004cited by this paper
• The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease.

  2004cited by this paper
• Urotensin II in the cardiovascular system.

  2004cited by this paper
• Mechanism of human urotensin II-induced contraction in rat aorta.

  2004cited by this paper
• Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats.

  2004cited by this paper
• Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heart.

  2004cited by this paper
• Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta.

  2004cited by this paper
• Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy.

  2004cited by this paper
• Human Urotensin II Modulates Collagen Synthesis and the Expression of MMP-1 in Human Endothelial Cells

  2004cited by this paper
• Intracerebroventricular administration of urotensin II promotes anxiogenic-like behaviors in rodents.

  2004cited by this paper
• Up-regulation of acyl-coenzyme A:cholesterol acyltransferase-1 by transforming growth factor-beta1 during differentiation of human monocytes into macrophages.

  2004cited by this paper
• Emerging roles of urotensin-II in cardiovascular disease.

  2004cited by this paper
• Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy.

  2004cited by this paper
• Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'?

  2003cited by this paper
• Increased plasma urotensin II levels in patients with diabetes mellitus.

  2003cited by this paper
• Central cardiovascular action of urotensin II in conscious rats

  2003cited by this paper
• Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta

  2003cited by this paper
• Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects

  2003cited by this paper
• Central cardiovascular action of urotensin II in spontaneously hypertensive rats.

  2003cited by this paper
• Deletion of the UT receptor gene results in the selective loss of urotensin‐II contractile activity in aortae isolated from UT receptor knockout mice

  2003cited by this paper
• A Comparison of Cerebrospinal Fluid and Plasma Urotensin II Concentrations in Normotensive and Hypertensive Patients Undergoing Urological Surgery During Spinal Anesthesia: A Pilot Study

  2003cited by this paper
• The Expression of Urotensin II Receptor (U2R) is Up‐regulated by Interferon‐γ

  2003cited by this paper
• Urotensin II-induced activation of extracellular signal-regulated kinase in cultured vascular smooth muscle cells: involvement of cell adhesion-mediated integrin signaling.

  2003cited by this paper
• Urotensin II Acts Centrally to Increase Epinephrine and ACTH Release and Cause Potent Inotropic and Chronotropic Actions

  2003cited by this paper
• Direct Actions of Urotensin II on the Heart: Implications for Cardiac Fibrosis and Hypertrophy

  2003cited by this paper
• Plasma Urotensin in Human Systolic Heart Failure

  2002cited by this paper
• Congestive heart failure and expression of myocardial urotensin II.

  2002cited by this paper
• Plasma urotensin II in heart failure.

  2002cited by this paper
• Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents

  2002cited by this paper
• G-protein-coupled receptors in human atherosclerosis: comparison of vasoconstrictors (endothelin and thromboxane) with recently de-orphanized (urotensin-II, apelin and ghrelin) receptors.

  2002cited by this paper
• Cardiovascular effects of urotensin II in different brain areas.

  2002cited by this paper
• High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man.

  2002cited by this paper
• No effect on central or peripheral blood pressure of systemic urotensin II infusion in humans.

  2002cited by this paper
• Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists.

  2002cited by this paper
• Effect of chronic hypoxia on contents of urotensin II and its functional receptors in rat myocardium

  2002cited by this paper
• Is urotensin‐II the new endothelin?

  2002cited by this paper
• Urotensin II evokes potent vasoconstriction in humans in vivo

  2002cited by this paper
• Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation

  2001cited by this paper
• Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension.

  2001cited by this paper
• Comparison of the contractile responses of human coronary bypass grafts and monkey arteries to human urotensin‐II

  2001cited by this paper

• Role of Rs228648 and Rs2890565 single nucleotide polymorphisms in Urotensin-2 gene in prostate cancer

  2025cites this paper
• Progress In the Chemistry and Pharmacology of Isoindolin‐1‐One Scaffolds

  2025cites this paper
• VASCULAR HEALTH IN BEHÇET’S DISEASE: THE ROLE OF UROTENSIN II AND SCLEROSTIN

  2024cites this paper
• Neuropeptides as Potential Biomarkers in Vascular Dementia.

  2024cites this paper
• Serum Urotensin II Levels Are Elevated in Patients with Obstructive Sleep Apnea

  2023cites this paper
• Effects of CBD supplementation on ambulatory blood pressure and serum urotensin-II concentrations in Caucasian patients with essential hypertension: A sub-analysis of the HYPER-H21-4 trial.

  2023cites this paper
• Identification of new target proteins of a Urotensin-II receptor antagonist using transcriptome-based drug repositioning approach

  2021cites this paper
• UROTENSIN-II AS A PROMISING KEY-POINTS OF CARDIOVASCUAL DISTURBANCES SEQUAL.

  2021cites this paper
• MiRNAs, lncRNAs, and circular RNAs as mediators in hypertension-related vascular smooth muscle cell dysfunction

  2020cites this paper
• Role of Urotensin-II in Saphenous Vein Graft Disease

  2020cites this paper
• Roles of the kisspeptin/GPR54 system in pathomechanisms of atherosclerosis.

  2020cites this paper
• The relation of left internal mammary artery atherosclerosis with urotensin-II.

  2020cites this paper
• Urotensin receptor antagonist palosuran attenuates cyclosporine-a-induced nephrotoxicity in rats.

  2019cites this paper
• Urotensin II promotes secretion of LTB4 through 5-lipoxygenase via the UT-ROS-Akt pathway in RAW264.7 macrophages

  2019influential citation
• Urotensin II: an inflammatory cytokine.

  2019cites this paper
• Functional Effects of Urotensin-II on Intracellular pH Regulators in Human Radial Artery Smooth Muscle Cells.

  2019cites this paper
• Urotensin receptors as a new target for CLP induced septic lung injury in mice

  2018cites this paper
• 14.11 – Vasoactive Substances as Mediators of Renal Injury

  2018cites this paper
• Emerging Roles of Cardiotrophin-1 in the Pathogenesis and Biomarker of Atherosclerosis

  2018cites this paper
• Pulmonary artery hypertension: pertinent vasomotorial cytokines

  2017cites this paper
• Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors.

  2017cites this paper
• Effect of urotensin II on apoptosis of H 9 c 2 cardiomyocytes and the underlying mechanisms

  2017cites this paper
• Synthèse en phase solide de pyrrolo[3,2-e][1,4]diazépin-2-ones modulateurs du système urotensinergétique

  2017cites this paper
• Study of urotensin-2 (T21M and S89N) gene polymorphisms in systemic sclerosis

  2017cites this paper
• A Novel Urotensin II Receptor Antagonist, KR-36996 Inhibits Smooth Muscle Proliferation through ERK/ROS Pathway

  2017cites this paper
• Induced Pluripotent Stem Cell Model of Pulmonary Arterial Hypertension Reveals Novel Gene Expression and Patient Specificity

  2017cites this paper
• The role of urotensin II and atherosclerotic risk factors in patients with slow coronary flow

  2016cites this paper
• Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.

  2016cites this paper
• Blockade of Urotensin II Receptor Prevents Vascular Dysfunction

  2016cites this paper
• Effects of urotensin-II on cytokines in early acute liver failure in mice.

  2015cites this paper
• Use of Diverse Chemometric and Validation Methods to Accurately Predict Human Urotensin-II Receptor Antagonist Activity.

  2015cites this paper
• Особенности суточного мониторирования артериального давления, сывороточного уровня уротензина II и ангиотензина II, васкулярного ремоделирования и экстракраниального кровотока у пациентов с артериальной гипертензией

  2015cites this paper
• В. А. Візір, В. В. Школовий, А. В. Абрамов Особливості добового моніторування артеріального тиску, сироваткового рівня уротензину II та ангіотензину II, васкулярного ремоделювання та екстракраніального кровотоку в пацієнтів з артеріальною гіпертензією

  2015cites this paper
• Urotensin II contributes to collagen synthesis and up-regulates Egr-1 expression in cultured pulmonary arterial smooth muscle cells through the ERK1/2 pathway.

  2015cites this paper
• Urotensin II increases foam cell formation by repressing ABCA1 expression through the ERK/NF-κB pathway in THP-1 macrophages.

  2014cites this paper
• Herz-Kreislauf und Lunge

  2014cites this paper
• Urotensin II Inhibits Doxorubicin-Induced Human Umbilical Vein Endothelial Cell Death by Modulating ATF Expression and via the ERK and Akt Pathway

  2014cites this paper
• Salusins: Potential Use as a Biomarker for Atherosclerotic Cardiovascular Diseases

  2013cites this paper
• Urotensin II-induced collagen synthesis in cultured smooth muscle cells from rat aortic media and a possible involvement of transforming growth factor-β1/Smad2/3 signaling pathway.

  2013cites this paper
• Design of multifunctional compounds for cardiovascular disease: from natural scaffolds to "classical" multitarget approach.

  2013cites this paper
• Association between Human Urotensin II and Essential Hypertension—A 1:1 Matched Case-Control Study

  2013cites this paper
• Inhibition of UII/UTR System Relieves Acute Inflammation of Liver through Preventing Activation of NF-κB Pathway in ALF Mice

  2013cites this paper
• Emerging roles for vasoactive peptides in diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseases.

  2013cites this paper
• Urotensin II levels in patients with chronic kidney disease and kidney transplants

  2012cites this paper
• Urotensin II in Invertebrates: From Structure to Function in Aplysia californica

  2012cites this paper
• The HIF1 target gene NOX2 promotes angiogenesis through urotensin-II

  2012cites this paper
• Endogenous Bioactive Peptides as Potential Biomarkers for Atherosclerotic Coronary Heart Disease

  2012cites this paper
• Urotensin II in the Pathogenesis of Atherosclerosis in Cholesterol Fed Rats

  2011cites this paper
• Obesity-Related Metabolic Syndrome: Investigations into Novel Clinical Markers and Possible Causes

  2011cites this paper
• La hipertensión arterial, ¿factor de riesgo para el síndrome serotoninérgico?

  2011cites this paper
• The interaction between human urotensin II and vasodilator agents in human internal mammary artery with possible clinical implications.

  2011cites this paper
• The roles of salusins in atherosclerosis and related cardiovascular diseases.

  2011cites this paper
• Gene expression in the adrenal glands of three spontaneously hypertensive rat substrains.

  2010cites this paper
• Urotensin-II as an angiogenic factor.

  2010cites this paper
• Urotensin-II receptor modulators as potential drugs.

  2010cites this paper
• Association between urotensin II gene polymorphism and pre-eclampsia.

  2010cites this paper
• Transforming growth factor-β1 involved in urotensin II-induced phenotypic differentiation of adventitial fibroblasts from rat aorta.

  2010cites this paper
• Vasoactive Substances As Mediators of Renal Injury

  2010cites this paper
• Increased plasma urotensin-II and carotid atherosclerosis are associated with vascular dementia.

  2009cites this paper